Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate‑to‑Severe Atopic Dermatitis – Butlletí de la Recerca

Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate‑to‑Severe Atopic Dermatitis

by biblioteca on 7 d'abril de 2026 with No hi ha comentaris

Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate‑to‑Severe Atopic Dermatitis
Convoca: Pfizer Inc
Termini: 13/05/2026

Deixa un comentari Cancel·la les respostes